These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28084189)

  • 1. Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort.
    Ahonkhai AA; Adeola J; Banigbe B; Onwuatuelo I; Adegoke AB; Bassett IV; Losina E; Freedberg KA; Okonkwo P; Regan S
    J Int Assoc Provid AIDS Care; 2017; 16(1):98-104. PubMed ID: 28084189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria.
    Ahonkhai AA; Banigbe B; Adeola J; Onwuatuelo I; Bassett IV; Losina E; Freedberg KA; Okonkwo P; Regan S
    BMC Infect Dis; 2015 Sep; 15():397. PubMed ID: 26424505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
    Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
    AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic outcomes of antiretroviral therapy among HIV-infected Nigerian children and its association with early infant feeding and nutritional status at treatment initiation.
    Omoni AO; Christian PS; Sadoh WE; Okechukwu A; Olateju E; Omoigberale A; Blattner W; Charurat ME
    Pediatr Infect Dis J; 2013 Jul; 32(7):e291-7. PubMed ID: 23411626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
    Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interruption of antiretroviral therapy in chronically HIV-infected patients].
    Amador C; Pasquau F; Ena J; Benito C; Ruiz de Apodaca RF
    Med Clin (Barc); 2005 Jun; 125(2):41-5. PubMed ID: 15970181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of attrition from antiretroviral care among adults in a rural HIV clinic in Coastal Kenya: a retrospective cohort study.
    Hassan AS; Mwaringa SM; Ndirangu KK; Sanders EJ; de Wit TF; Berkley JA
    BMC Public Health; 2015 May; 15():478. PubMed ID: 25957077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria.
    Aliyu MH; Blevins M; Parrish DD; Megazzini KM; Gebi UI; Muhammad MY; Ahmed ML; Hassan A; Shepherd BE; Vermund SH; Wester CW
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):e41-9. PubMed ID: 23727981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study.
    Conen A; Wang Q; Glass TR; Fux CA; Thurnheer MC; Orasch C; Calmy A; Bernasconi E; Vernazza P; Weber R; Bucher HC; Battegay M; Fehr J
    J Acquir Immune Defic Syndr; 2013 Dec; 64(5):472-8. PubMed ID: 23892243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
    Kaplan SR; Oosthuizen C; Stinson K; Little F; Euvrard J; Schomaker M; Osler M; Hilderbrand K; Boulle A; Meintjes G
    PLoS Med; 2017 Nov; 14(11):e1002407. PubMed ID: 29112692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count.
    Wang B; Losina E; Stark R; Munro A; Walensky RP; Wilke M; Martin D; Lu Z; Freedberg KA; Wood R
    S Afr Med J; 2011 Apr; 101(4):253-7. PubMed ID: 21786730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4⁺ cell counts: findings from a cluster-randomized trial.
    Woodd SL; Grosskurth H; Levin J; Amuron B; Namara G; Birunghi J; Coutinho A; Jaffar S
    AIDS; 2014 Feb; 28(4):569-76. PubMed ID: 24468997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study.
    Dorward J; Sookrajh Y; Gate K; Khubone T; Mtshaka N; Mlisana K; Ngobese H; Yende-Zuma N; Garrett N
    J Int AIDS Soc; 2020 Apr; 23(4):e25479. PubMed ID: 32319203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria.
    Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O
    PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.